DESIGN THERAPEUTICS INC shareholders Q2 2023

DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 98 filers reported holding DESIGN THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 3.50 and the average weighting 0.2%.

DESIGN THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
STATE OF WISCONSIN INVESTMENT BOARD 84,000$529,2000.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 16,100$101,4300.00%
GOLDMAN SACHS GROUP INC 447,416$2,818,7210.00%
WELLINGTON MANAGEMENT GROUP LLP 502,375$3,164,9630.00%
BlackRock Inc. 2,994,051$18,862,5230.00%
Verition Fund Management LLC 11,786$74,2520.00%
TWO SIGMA ADVISERS, LP 79,000$497,7000.00%
US BANCORP \DE\ 438$2,7590.00%
SIGNATUREFD, LLC 1,211$7,6290.00%
Parallel Advisors, LLC 102$6430.00%
BANK OF AMERICA CORP /DE/ 77,878$490,6310.00%
Russell Investments Group, Ltd. 1,394$8,7820.00%
ROYAL BANK OF CANADA 3,574$23,0000.00%
WELLS FARGO & COMPANY/MN 12,463$78,5170.00%
NORTHERN TRUST CORP 324,738$2,045,8490.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 15,173$95,5900.00%
Legal & General Group Plc 3,127$19,7470.00%
GEODE CAPITAL MANAGEMENT, LLC 636,845$4,012,1230.00%
BALYASNY ASSET MANAGEMENT L.P. 18,499$116,5440.00%
External links

This page lists DESIGN THERAPEUTICS INC's shareholders in Q2 2023. To view DESIGN THERAPEUTICS INC's shareholder history, click here.